These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20822110)

  • 41. Polymeric micelles with small lipophilic moieties for drug delivery.
    Li D; Liang Y; Lai Y; Wang G; He B; Gu Z
    Colloids Surf B Biointerfaces; 2014 Apr; 116():627-32. PubMed ID: 24268560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors.
    Ibrahim HS; Eldehna WM; Fallacara AL; Ahmed ER; Ghabbour HA; Elaasser MM; Botta M; Abou-Seri SM; Abdel-Aziz HA
    Future Med Chem; 2018 Dec; 10(24):2771-2789. PubMed ID: 30526032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A carbohydrate mimetic peptide modified size-shrinkable micelle nanocluster for anti-tumor targeting and penetrating drug delivery.
    Chen Q; Liang H; Sun Y; Chen Y; He W; Fang X; Sha X; Li J
    Int J Nanomedicine; 2019; 14():7339-7352. PubMed ID: 31686810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.
    Huang Y; Lu J; Gao X; Li J; Zhao W; Sun M; Stolz DB; Venkataramanan R; Rohan LC; Li S
    Bioconjug Chem; 2012 Jul; 23(7):1443-51. PubMed ID: 22681537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Click chemistry approach for imaging intracellular and intratissue distribution of curcumin and its nanoscale carrier.
    Luo Z; Tikekar RV; Nitin N
    Bioconjug Chem; 2014 Jan; 25(1):32-42. PubMed ID: 24328059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linker chemistry determines secondary structure of p5314-29 in peptide amphiphile micelles.
    Missirlis D; Farine M; Kastantin M; Ananthanarayanan B; Neumann T; Tirrell M
    Bioconjug Chem; 2010 Mar; 21(3):465-75. PubMed ID: 20166676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions.
    Philippe G; Huang YH; Cheneval O; Lawrence N; Zhang Z; Fairlie DP; Craik DJ; de Araujo AD; Henriques ST
    Biopolymers; 2016 Nov; 106(6):853-863. PubMed ID: 27287767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres.
    Gonzalez AZ; Li Z; Beck HP; Canon J; Chen A; Chow D; Duquette J; Eksterowicz J; Fox BM; Fu J; Huang X; Houze J; Jin L; Li Y; Ling Y; Lo MC; Long AM; McGee LR; McIntosh J; Oliner JD; Osgood T; Rew Y; Saiki AY; Shaffer P; Wortman S; Yakowec P; Yan X; Ye Q; Yu D; Zhao X; Zhou J; Olson SH; Sun D; Medina JC
    J Med Chem; 2014 Apr; 57(7):2963-88. PubMed ID: 24601644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipidated gemini peptide amphiphiles with enhanced loading capacity and cell membrane affinity for drug delivery.
    Yin X; Chen Z; Chen Y; Xie Y; Xiong B; Jiang H; Zhu J
    Colloids Surf B Biointerfaces; 2020 Nov; 195():111271. PubMed ID: 32736122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme-Triggered Disassembly of Polymeric Micelles by Controlled Depolymerization via Cascade Cyclization for Anticancer Drug Delivery.
    Park J; Jo S; Lee YM; Saravanakumar G; Lee J; Park D; Kim WJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8060-8070. PubMed ID: 33576220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic Peptide Amphiphile as a Drug Carrier with ATP-Triggered Release for Synergistic Effect, Improved Therapeutic Index, and Penetration of 3D Cancer Cell Spheroids.
    Lu S; Zhao F; Zhang Q; Chen P
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An implantable depot capable of in situ generation of micelles to achieve controlled and targeted tumor chemotherapy.
    Luo X; Chen M; Chen Z; Xie S; He N; Wang T; Li X
    Acta Biomater; 2018 Feb; 67():122-133. PubMed ID: 29242159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles.
    Wang X; Yang C; Zhang Y; Zhen X; Wu W; Jiang X
    Biomaterials; 2014 Aug; 35(24):6439-53. PubMed ID: 24811257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
    Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
    Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Supramolecular Assembly of Coronene Derivatives for Drug Delivery.
    Yu J; Chen Y; Zhang YH; Xu X; Liu Y
    Org Lett; 2016 Sep; 18(18):4542-5. PubMed ID: 27589016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supramolecular "Trojan Horse" for Nuclear Delivery of Dual Anticancer Drugs.
    Cai Y; Shen H; Zhan J; Lin M; Dai L; Ren C; Shi Y; Liu J; Gao J; Yang Z
    J Am Chem Soc; 2017 Mar; 139(8):2876-2879. PubMed ID: 28191948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.